BALANCE SHEETS - USD ($)	Mar. 31, 2019	Sep. 30, 2018
CURRENT ASSETS:
Cash and cash equivalents	$ 5,514,013	$ 10,310,044
Receivables	123,236	118,657
Prepaid expenses	355,948	364,622
Inventory used for R&D and manufacturing	761,012	645,238
Total current assets	6,754,209	11,438,561
Plant, property and equipment, net	16,086,828	16,218,851
Patent costs, net	243,253	258,093
Deposits	1,670,917	1,670,917
Total Assets	24,755,207	29,586,422
CURRENT LIABILITIES:
Accounts payable	4,158,732	5,743,913
Accrued expenses	287,890	205,310
Due to employees	1,010,015	764,941
Derivative instruments, current portion	0	2,498,606
Other current liabilities	13,984	14,029
Total current liabilities	5,470,621	9,226,799
Derivative instruments - net of current portion	4,727,929	6,818,458
Lease Liability	13,444,394	13,379,962
Deferred income	126,849	126,795
Other liabilities	29,892	33,492
Total liabilities	23,799,685	29,585,506
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 29,951,628 and 28,034,487 shares issued and outstanding at March 31, 2019 and September 30, 2018, respectively	299,517	280,346
Additional paid-in capital	337,449,398	331,312,184
Accumulated deficit	(336,793,393)	(331,591,614)
Total stockholders' equity	955,522	916
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 24,755,207	$ 29,586,422